Recent studies have shown CD93 to be intensely upregulated on tumor-associated endothelium, supported by its status as one of the top 20 genes associated with human primary tumor angiogenesis signature surveying head and neck, breast, kidney, and brain tumors [30]. The gene discussed is CD93; the disease is neoplasm.